Effects of Hwangryungeehwang-tang Aqueous extracts on streptozotocin-induced diabetic rat

DJ Yu, GM Yoon, SB Kang - The Journal of Internal Korean …, 2011 - koreascience.kr
Objectives: The object of this study was to observe the effects of Hwangryungeehwang-tang
(HRGHT), which has traditionally been used in Korean medicine for treating diabetes, by …

Rosuwastatyna w prewencji pierwotnej schorzeń układu sercowo-naczyniowego

G Grześk, A El-Essa, A Kubica, E Grześk… - Folia …, 2010 - journals.viamedica.pl
Statyny należą do najczęściej stosowanych grup leków na świecie. Poza działaniem
hipolipemizującym wywierają wpływ na wiele działań pozalipidowych. Szczególnie …

[引用][C] Study to Evaluate the Safety of the Fixed-dose Combination Rosuvastatin/Ezetimibe for Patients With Dyslipidaemia

MI Flores, CC SC

Effects of Chunglijagam-tang Aqueous Extracts on streptozotocin-induced rat diabetes and related complications

YS Park, GM Yoon, EY Im, HC Shin… - The Journal of Internal …, 2010 - koreascience.kr
Objective: The object of this study was to observe the effects of aqueous extracts of
Chunglijagam-tang (CLJGT), which has traditionally been used in Korean medicine for …

Avancées récentes et perspectives dans le traitement des dyslipidémies athérogènes

FC Aubart, B Hansel, JS Hulot, P Lechat… - La Revue de médecine …, 2007 - Elsevier
Résumé Propos Au cours des 30 dernières années, de grandes avancées ont permis
d'identifier des facteurs de risque cardiovasculaire et mettre en place des mesures pour les …

Cardiovascular risk associated with antiretroviral therapy in HIV-infected patients

DL Calza, R Manfredi, F Chiodo - Expert Opinion on Therapeutic …, 2006 - Taylor & Francis
Cardiovascular risk factors, including the fat redistribution syndrome, dyslipidaemia, insulin
resistance and diabetes mellitus, have been increasingly described in association with new …

High-intensity therapy: rationale, indications and safety issues. Prospects of rosuvastatin in clinical practice

MG Bubnova - CardioSomatics, 2017 - cardiosomatics.orscience.ru
The review is devoted to the problem of high-intensity therapy. Evidence of the effectiveness
of statin prescribing in high-intensity mode is presented to patients with very high …

[PDF][PDF] PHARMACEUTICAL SYNTHETIC REVIEW OF ROSUVASTATIN CALCIUM

P Patil, DV Nagarale, BR Chaudhari - 2017 - wjpr.s3.ap-south-1.amazonaws.com
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and
related conditions, and to prevent cardiovascular disease. It was developed by Shionogi …

[HTML][HTML] Высокоинтенсивная терапия: обоснование, показания и вопросы безопасности. Перспективы розувастатина в клинической практике

МГ Бубнова - CardioСоматика, 2017 - cyberleninka.ru
Представленный обзор посвящен проблеме высокоинтенсивной терапии.
Представлены доказательства эффективности назначения статинов в режиме …

[PDF][PDF] Research Journal of Pharmaceutical, Biological and Chemical Sciences

IBH Fat-Diet - researchgate.net
Hyperlipidemia is excessive amounts of fatty substance in the blood. In the present study,
the effects of silver nanoparticles and rosuvastatin on serum lipid profile in high cholesterol …